Arrival SA (ARVL) Stock Price Today
Cycurion faces Nasdaq delisting over low stock price but appeals to maintain trading and shareholder value.
Cycurion received a Nasdaq delisting notice due to its stock price falling below the $1 minimum for 31 consecutive days. The company is appealing the decision, which allows its shares to keep trading on Nasdaq during the review. Cycurion is focused o...

Gold and silver prices drop sharply as strong US data and higher yields outweigh inflation and geopolitical risks.
Gold and silver prices fell significantly on Thursday, with gold dropping over 2% below the $4,000 mark and silver declining nearly 4%. This decline was driven by strong U.S. economic data, including rising retail sales and lower jobless claims, whic...

Pentair CFO departure and EPS cut spark shareholder loss investigation
Pentair announced CFO Nicholas J. Brazis's departure effective July 10, 2026, alongside a significant cut in FY2026 EPS guidance from $5.30-$5.40 to $4.60-$4.80. This announcement caused immediate losses for shareholders and prompted an investigation...

Netflix says no big M&A plans, focuses on partnerships and cautious growth after mixed Q2 results.
Netflix Co-CEOs Ted Sarandos and Greg Peters clarified that the company remains focused on building through producing, licensing, and partnerships rather than pursuing major mergers and acquisitions (M&A). This statement came after Netflix reported m...

Lawsuit filed against Regeneron over misleading drug trial data causing stock price drop
Levi & Korsinsky, LLP has filed a class action lawsuit against Regeneron Pharmaceuticals, alleging the company misled investors about its Phase III Fianlimab-Libtayo study results. The complaint claims Regeneron made false positive statements while c...

Lawsuit filed against Regeneron over misleading trial data causing stock price drop
Levi & Korsinsky, LLP has filed a class action lawsuit against Regeneron Pharmaceuticals for allegedly providing false and misleading information about its Phase III Fianlimab-Libtayo study. The complaint claims Regeneron concealed that the trial was...

New court action filed against Belo Sun over indigenous consultation at Volta Grande gold project
Belo Sun Mining Corp. announced a new civil public action filed in Brazil by the Federal Public Defender’s Office against its Brazilian subsidiary concerning the Volta Grande Gold Project. The lawsuit demands free, prior, and informed consultation wi...

Onco-Innovations starts ADME studies to advance cancer drug ONC010 toward clinical trials
Onco-Innovations has initiated key ADME (absorption, distribution, metabolism, and excretion) studies for ONC010, its lead cancer drug candidate targeting DNA repair enzyme PNKP. These studies aim to understand ONC010's pharmacokinetics and metabolis...

US economy shows strong growth with stable prices, signaling a new 'Goldilocks economy' driven by tech and productivity.
Recent US economic data reveal strong consumer spending, especially online sales and car purchases, alongside declining inflation rates. This combination suggests a 'Goldilocks economy' where rapid growth coexists with stable or falling prices, drive...

Deadline nears for investors to lead class actions against BMI, PICS, VRRM, and others over alleged securities fraud.
Law Offices of Howard G. Smith reminds investors of upcoming deadlines to file lead plaintiff motions in securities fraud class actions involving Badger Meter, PicS N.V., Verra Mobility, and Grail, Inc. The lawsuits allege these companies made mislea...

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.